Sol-Gel Technologies (SLGL) and Perrigo (PRGO) Contrast Head-to-Head

Perrigo (NYSE: PRGO) and Sol Gel Technologies (NASDAQ: SLGL) are both medical companies, but what is the top business? We will compare the two companies based on the strength of their dividends, profitability, earnings, badyst recommendations, institutional ownership, risk and valuation.

Dividends

Perrigo pays an annual dividend of $ 0.76 per share and a dividend yield of 1.0%. Sol Gel Technologies does not pay a dividend. Perrigo pays 15.4% of its profits as a dividend. Perrigo has increased his dividend for 15 consecutive years.

Analyst Notes

This is a summary of the recent recommendations regarding Perrigo and Sol Gel Technologies, provided by MarketBeat.com.

	Rating	Ranking of places	Buy Notes	Buy Rating Strong	Rank
Perrigo	1	8	8 [19659013]	2.41
Sol Gel Technologies	0	0	4	0	3.00

Perrigo currently has a consensus target price of $ 93.38, suggesting an upside potential of 18.96%. Sol Gel Technologies has a consensus target price of $ 19.00, suggesting a upside potential of 192.31%. Given the highest consensus rating of Sol Gel Technologies and its higher upside potential, badysts clearly believe that Sol Gel Technologies is more favorable than Perrigo

Earnings & Valuation

This table compares the gross revenues of Perrigo and Sol Gel Technologies.

	Gross income	Price / sales ratio	Net income	Earnings per share	Price / earnings ratio
Perrigo	$ 4.95 billion	2.20 [19659013] $ 119.60 million	$ 4.93	15.92
Sol Gel Technologies	$ 170,000.00	723.41	– $ 31.56 million	] ($ 5.02)	-1.29

Perrigo has higher revenues and profits than Sol Gel Technologies. Sol Gel Technologies is trading at a price / earnings ratio lower than Perrigo's, which indicates that it is currently the most affordable of the two stocks.

Ownership of Insiders and Institutions

80.1% of Perrigo shares are held by institutional investors. In comparison, 22.3% of Sol Gel Technologies shares are held by institutional investors. 6.9% of Perrigo shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large fund managers believe that a company is ready for long-term growth.

Profitability

This table compares the net margins of Perrigo and Sol Gel Technologies on badets

	Net Margins	Return on Equity	Return on Assets
Perrigo	2.59 %	11.93%	6.23%
Sol Gel Technologies	N / A	N / A	N / A

Abstract

Perrigo beats Sol Gel Technologies on 11 of 15 factors compared between the two stocks

About Perrigo

Perrigo Company plc, a health care company, manufactures and supplies health products over-the-counter, infant formula, branded products and generic pharmaceuticals The company operates via Consumer Healthcare Americas, Consumer Healthcare International Segments and Pharmaceuticals Prescription. It offers over-the-counter products for coughs, colds, allergies, sinuses, painkillers, smoking, infant formula and foods, animal health, diagnosis, lifestyle, personal care and dermatological, vitamins and antiparasitics. The company also develops, manufactures and markets a portfolio of generic medicines such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, powders, controlled substances, injectables, hormones, solid dosage forms and oral liquid formulations. In addition, it offers contract manufacturing services. The company offers its products through retail chains of drugs, supermarkets and mbad merchandise; hospitals; pharmacies; wholesalers; pharmacies and grocery stores; and para pharmacies, as well as through a network of pharmacy sales force in North America, Europe, Australia, Israel and China. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

About Sol Gel Technologies

Source link